IRLAB Therapeutics AB (publ) announced that in preparation for the annual general meeting 2020, the company's three shareholders, or groups of shareholders, have appointed members of the nomination committee. The nomination committee consists of Bo Rydlinger, Daniel Johnsson and Clas Sonesson beside Anders Vedin, the chairman of the board.